Carol Meschonat

536 total citations
16 papers, 420 citations indexed

About

Carol Meschonat is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Carol Meschonat has authored 16 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Carol Meschonat's work include PI3K/AKT/mTOR signaling in cancer (12 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Mast cells and histamine (4 papers). Carol Meschonat is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (12 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Mast cells and histamine (4 papers). Carol Meschonat collaborates with scholars based in United States and Czechia. Carol Meschonat's co-authors include Benjamin D.�L. Li, Quyen D. Chu, Fleurette Abreo, Donald L. Sorrells, Destin Black, Lester W. Johnson, Herbert Yu, Arrigo De Benedetti, John C. McDonald and Richard H. Turnage and has published in prestigious journals such as Cancer Research, Annals of Surgery and Journal of the American College of Surgeons.

In The Last Decade

Carol Meschonat

16 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol Meschonat United States	12	323	107	82	64	47	16	420
Kelly Dobler Canada	5	230 0.7×	102 1.0×	82 1.0×	79 1.2×	48 1.0×	8	372
Srimathi Srinivasan United States	9	208 0.6×	160 1.5×	61 0.7×	93 1.5×	38 0.8×	15	408
Marja‐Riitta Väisänen Finland	11	169 0.5×	97 0.9×	84 1.0×	90 1.4×	46 1.0×	12	392
Barbara Szymanska Australia	6	306 0.9×	140 1.3×	77 0.9×	75 1.2×	16 0.3×	7	499
Wendy A. Hudson United States	11	520 1.6×	95 0.9×	58 0.7×	87 1.4×	18 0.4×	15	720
Alex Murison Canada	9	445 1.4×	120 1.1×	104 1.3×	84 1.3×	15 0.3×	16	584
Mahdhia Soula-Rothhut France	8	262 0.8×	98 0.9×	121 1.5×	135 2.1×	25 0.5×	9	406
Dailia B. Francis United States	4	323 1.0×	98 0.9×	90 1.1×	31 0.5×	15 0.3×	5	403
Nalini Venkatesan India	14	259 0.8×	141 1.3×	146 1.8×	107 1.7×	21 0.4×	25	445
Sharon A. Townson United States	9	474 1.5×	56 0.5×	70 0.9×	39 0.6×	70 1.5×	18	592

Countries citing papers authored by Carol Meschonat

Since Specialization

Citations

This map shows the geographic impact of Carol Meschonat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Meschonat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Meschonat more than expected).

Fields of papers citing papers by Carol Meschonat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Meschonat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Meschonat. The network helps show where Carol Meschonat may publish in the future.

Co-authorship network of co-authors of Carol Meschonat

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Meschonat. A scholar is included among the top collaborators of Carol Meschonat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Meschonat. Carol Meschonat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hiller, D., Carol Meschonat, Roger H. Kim, Benjamin D.�L. Li, & Quyen D. Chu. (2011). Chemokine receptor CXCR4 level in primary tumors independently predicts outcome for patients with locally advanced breast cancer. Surgery. 150(3). 459–465. 24 indexed citations

Kleiner, Heather E., K. C. Prasad, Carol Meschonat, et al.. (2009). Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. Journal of Experimental & Clinical Cancer Research. 28(1). 5–5. 21 indexed citations

Chu, Quyen D., et al.. (2009). Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome. Surgery. 146(2). 220–226. 26 indexed citations

Hiller, D., et al.. (2009). Predictive Value of eIF4E Reduction After Neoadjuvant Therapy in Breast Cancer. Journal of Surgical Research. 156(2). 265–269. 11 indexed citations

Chu, Quyen D., et al.. (2008). Hypoxia induces CXCR4 overexpression in pancreatic cancer cells. Cancer Research. 68. 4472–4472. 1 indexed citations

Johnson, Lester W., et al.. (2008). A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Negative Breast Cancer. Annals of Surgical Oncology. 15(11). 3207–3215. 23 indexed citations

Siegele, Bradford, Guang Sun, Carol Meschonat, et al.. (2008). eIF4E-Targeted Suicide Gene Therapy in a Minimal Residual Mouse Model for Metastatic Soft-Tissue Head and Neck Squamous Cell Carcinoma Improves Disease-Free Survival. Journal of Surgical Research. 148(1). 83–89. 5 indexed citations

Chu, Quyen D., et al.. (2007). Correlation of TLK1B in Elevation and Recurrence in Doxorubicin-Treated Breast Cancer Patients with High eIF4E Overexpression. Journal of the American College of Surgeons. 204(5). 925–933. 18 indexed citations

Chu, Quyen D., Carol Meschonat, Herbert Yu, et al.. (2006). High eIF4E, VEGF, and Microvessel Density in Stage I to III Breast Cancer. Annals of Surgery. 243(5). 684–692. 48 indexed citations

10.

Chu, Quyen D., Herbert Yu, Lester W. Johnson, et al.. (2005). A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Positive Breast Cancer. Annals of Surgery. 242(4). 584–592. 40 indexed citations

11.

Sen, Siddhartha, et al.. (2004). TLK1B is elevated with eIF4E overexpression in breast cancer. Journal of Surgical Research. 116(1). 98–103. 21 indexed citations

12.

Zhang, Jun, Ravi Shridhar, Qun Dai, et al.. (2004). Cystatin M. Cancer Research. 64(19). 6957–6964. 72 indexed citations

13.

Sorrells, Donald L., Ghali E. Ghali, Carol Meschonat, et al.. (1999). Competitive PCR to detect eIF4E gene amplification in head and neck cancer. Head & Neck. 21(1). 60–65. 28 indexed citations

14.

Sorrells, Donald L., Ghali E. Ghali, Carol Meschonat, et al.. (1999). Competitive PCR to detect eIF4E gene amplification in head and neck cancer. Head & Neck. 21(1). 60–65. 2 indexed citations

15.

Sorrells, Donald L., Carol Meschonat, Destin Black, & Benjamin D.�L. Li. (1999). Pattern of Amplification and Overexpression of the Eukaryotic Initiation Factor 4E Gene in Solid Tumor. Journal of Surgical Research. 85(1). 37–42. 37 indexed citations

16.

Sorrells, Donald L., Destin Black, Carol Meschonat, et al.. (1998). Detection of eIF4E gene amplification in breast cancer by competitive PCR. Annals of Surgical Oncology. 5(3). 232–237. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact